Journal article

Metabolic Response of Rectal Cancer Assessed by 18-FDG PET Following Chemoradiotherapy is Prognostic for Patient Outcome

JMC Yeung, V Kalff, RJ Hicks, E Drummond, E Link, Y Taouk, M Michael, S Ngan, AC Lynch, AG Heriot

Diseases of the Colon and Rectum | LIPPINCOTT WILLIAMS & WILKINS | Published : 2011

DOI: 10.1007/DCR.0b013e31820b36f0

Citation metrics

23Web of Science
23Scopus

Keywords

Disease-Free Survival
Preoperative Chemoradiation
Humans
Female
Adult
Aged, 80 and Over
Fdg-Pet/ct
Radiopharmaceuticals
Male
Life Sciences & Biomedicine
Rectal Cancer
Neoadjuvant Chemoradiation
Fluorodeoxyglucose F18
Pet
Esophageal Cancer
Chemotherapy
Outcomes Research
Middle Aged
Treatment Outcome
Gastroenterology & Hepatology
Science & Technology
Rectal Neoplasms
Surgery
Radiotherapy, Adjuvant
Antineoplastic Agents
Positron-Emission Tomography
Management
Positron-Emission-Tomography
Colorectal-Cancer
Complete Pathological Response
F-18-Fdg Pet
Follow-Up Studies
Aged
Prospective Studies